Cytokinetics Overview
Cytokinetics Target Price
See Cytokinetics's analyst price targets ($110) vs the current share price.
Get informed when a big investor buys or sells
+ FollowShare Price
$76.76
Average Target Price
$113.67
48.1% upside
48.1% upside12 analysts in the last 4 months
High: $140 | Low: $95
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-08-07 | NeedhamSerge Belanger | $112 | 45.9% upside |  |
| 2026-08-07 | RBC CapitalLeonid Timashev | $112 | 45.9% upside | |
| 2026-07-07 | RBC CapitalLeonid Timashev | $117 | 52.4% upside | |
| 2026-06-29 | UBSAshwani Verma | $115 | 49.8% upside | |
| 2026-06-24 | Mizuho Securities | $118 | 53.7% upside | |
| 2026-06-17 | RBC CapitalLeonid Timashev | $119 | 55% upside | |
| 2026-05-11 | H.C. Wainwright | $140 | 82.4% upside | |
| 2026-05-06 | Morgan Stanley | $103 | 34.2% upside | |
| 2026-05-06 | UBS | $119 | 55% upside | |
| 2026-05-06 | Stifel Nicolaus | $108 | 40.7% upside | |
| 2026-05-05 | Truist FinancialSrikripa Devarakonda | $106 | 38.1% upside | |
| 2026-04-10 | Wells Fargo | $95 | 23.8% upside | |
| 2026-03-10 | Robert W. BairdRoanna Ruiz | $84 | 9.4% upside | |
| 2026-03-06 | UBSAshwani Verma | $69 |  10.1% downside | |
| 2026-02-20 | RBC Capital | $101 | 31.6% upside | |
| 2026-02-03 | Truist FinancialSrikripa Devarakonda | $92 | 19.9% upside | |
| 2026-01-09 | JefferiesAkash Tewari | $90 | 17.2% upside | |
| 2026-01-08 | Morgan StanleyMaxwell Skor | $90 | 17.2% upside | |
| 2025-12-22 | Truist FinancialSrikripa Devarakonda | $84 | 9.4% upside | |
| 2025-12-22 | Morgan Stanley | $71 | 7.5% downside | |
| 2025-12-22 | Leerink PartnersRoanna Ruiz | $83 | 8.1% upside | |
| 2025-12-22 | RBC Capital | $95 | 23.8% upside | |
| 2025-12-22 | NeedhamSerge Belanger | $84 | 9.4% upside | |
| 2025-12-22 | Goldman Sachs | $99 | 29% upside | |
| 2025-12-22 | H.C. WainwrightJoseph Pantginis | $136 | 77.2% upside | |
| 2025-12-22 | Barclays | $87 | 13.3% upside | |
| 2025-12-18 | Goldman Sachs | $95 | 23.8% upside | |
| 2025-12-01 | UBSAshwani Verma | $61 | 20.5% downside | |
| 2025-10-06 | BarclaysGena Wang | $82 | 6.8% upside | |
| 2025-09-03 | Evercore ISICory Kasimov | $80 | 4.2% upside | |
| 2025-09-03 | BarclaysGena Wang | $71 | 7.5% downside | |
| 2025-09-02 | Stifel NicolausJames Condulis | $96 | 25.1% upside | |
| 2025-04-24 | BarclaysGena Wang | $55 | 28.3% downside | |
| 2025-03-07 | Morgan Stanley | $67 | 12.7% downside | |
| 2024-10-17 | H.C. WainwrightJoseph Pantginis | $120 | 56.3% upside | |
| 2024-09-03 | Goldman SachsPaul Choi | $60 | 21.8% downside | |
| 2024-06-10 | Piper SandlerYasmeen Rahimi | $107 | 39.4% upside | |
| 2024-06-04 | B.Riley FinancialMayank Mamtani | $92 | 19.9% upside | |
| 2024-05-28 | JMP SecuritiesJason Butler | $78 | 1.6% upside | |
| 2024-05-23 | H.C. WainwrightJoseph Pantginis | $90 | 17.2% upside | |
| 2024-05-23 | NeedhamSerge Belanger | $72 | 6.2% downside | |
| 2024-05-23 | JefferiesAkash Tewari | $85 | 10.7% upside | |
| 2024-05-23 | BarclaysCarter Gould | $95 | 23.8% upside | |
| 2024-05-09 | OppenheimerJustin Kim | $106 | 38.1% upside | |
| 2024-05-09 | JMP SecuritiesJason Butler | $106 | 38.1% upside | |
| 2024-04-05 | Mizuho SecuritiesSalim Syed | $99 | 29% upside | |
| 2022-12-23 | Needham | $58 | 24.4% downside | |
| 2022-12-20 | Truist Financial | $60 | 21.8% downside | |
| 2022-08-23 | Raymond JamesDane Leone | $63 | 17.9% downside | |
| 2022-06-09 | Piper SandlerYasmeen Rahimi | $72 | 6.2% downside | |